Eng‐Siew Koh

2.1k total citations
69 papers, 1.3k citations indexed

About

Eng‐Siew Koh is a scholar working on Genetics, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Eng‐Siew Koh has authored 69 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Genetics, 23 papers in Pulmonary and Respiratory Medicine and 19 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Eng‐Siew Koh's work include Glioma Diagnosis and Treatment (31 papers), Radiomics and Machine Learning in Medical Imaging (11 papers) and Brain Metastases and Treatment (10 papers). Eng‐Siew Koh is often cited by papers focused on Glioma Diagnosis and Treatment (31 papers), Radiomics and Machine Learning in Medical Imaging (11 papers) and Brain Metastases and Treatment (10 papers). Eng‐Siew Koh collaborates with scholars based in Australia, United States and Canada. Eng‐Siew Koh's co-authors include M. Heydarian, Tu Tran, Richard Tsang, David Hodgson, Melania Pintilie, Rainer K. Sachs, David J. Brenner, Geoff P. Delaney, Lois Holloway and Barbara‐Ann Millar and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Eng‐Siew Koh

64 papers receiving 1.2k citations

Peers

Eng‐Siew Koh
Comparison fields: 5 of 92
  • Pulmonary and Respiratory Medicine 512
  • Pathology and Forensic Medicine 315
  • Oncology 279
  • Radiology, Nuclear Medicine and Imaging 279
  • Genetics 265
Replace Julie A. Bradley with:
Julie A. Bradley United States
Katherine Zukotynski Canada
David Shultz Canada
Mike Hawkins United Kingdom
Joseph Anderson United States
Patrizia Ciammella Italy
Rita E. Weathers United States
Christine E. Hill‐Kayser United States
Grit Welzel Germany
Torgil R. Möller Sweden
Julie A. Bradley United States View profile →
Citations per field, relative to Eng‐Siew Koh
Eng‐Siew Koh · 1×
Citations per year, relative to Eng‐Siew Koh
Eng‐Siew Koh · 1×

Countries citing papers authored by Eng‐Siew Koh

Since Specialization
Citations

This map shows the geographic impact of Eng‐Siew Koh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eng‐Siew Koh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eng‐Siew Koh more than expected).

Fields of papers citing papers by Eng‐Siew Koh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eng‐Siew Koh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eng‐Siew Koh. The network helps show where Eng‐Siew Koh may publish in the future.

Co-authorship network of co-authors of Eng‐Siew Koh

This figure shows the co-authorship network connecting the top 25 collaborators of Eng‐Siew Koh. A scholar is included among the top collaborators of Eng‐Siew Koh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eng‐Siew Koh. Eng‐Siew Koh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 0
2 0
3 0
4 2
5 3
6 1
7 0
8 4
9 3
10 43
11 26
12 51
13 33
14
A RANDOMIZED PHASE II TRIAL OF VELIPARIB (V), RADIOTHERAPY (RT) AND TEMOZOLOMIDE (TMZ) IN PATIENTS (PTS) WITH UNMETHYLATED MGMT (uMGMT) GLIOBLASTOMA (GBM): THE VERTU STUDY
1
15
ATHENA (GOG-3020/ENGOT-ov45): A randomised, double-blind, placebo-controlled, phase 3 study of rucaparib plus nivolumab following front-line platinum-based chemotherapy in ovarian cancer
1
16 17
17 8
18 16
19 33
20 238

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026